Evidence map›Paper›PMID 26135263›Full record

ReviewEndoscopy international open2014

Gastric antral vascular ectasia: the evolution of therapeutic modalities.

Harini Naidu, Qin Huang, Hiroshi Mashimo

Open access · goldAbstract readReview
In one paragraph

Review in Endoscopy international open, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. Risk factors for bleeding from gastric antral vascular ectasia.The Korean journal of internal medicine · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Endoscopy international open · 2022
    Article
  7. Gastric antral vascular ectasia in hepatitis C virus related liver cirrhosis: Fetching for predictors.JGH open : an open access journal of gastroenterology and hepatology · 2021
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Harini NaiduDepartment of Internal Medicine, Boston University Medical Center, Boston, Massachusetts, United States.
Qin HuangDepartment of Gastroenterology, VA Boston Healthcare System, Boston, Massachusetts, United States ; Department of Pathology, Harvard Medical School, Boston, Massachusetts, United States.
Hiroshi MashimoDepartment of Gastroenterology, VA Boston Healthcare System, Boston, Massachusetts, United States ; Department of Pathology, Harvard Medical School, Boston, Massachusetts, United States.
Harvard University · USBoston University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastric Antral Vascular Ectasia (GAVE) may be an enigmatic source of non-variceal upper GI bleeding associated with various systemic diseases such as connective tissue disorders, liver disease, and chronic renal failure. Successful treatment of GAVE continues to be a challenge and has evolved through the years. Currently, given the rapid response, safety, and efficacy, endoscopic ablative modalities have largely usurped medical treatments as first-line therapy, particularly using argon plasma coagulation. However, other newer ablative modalities such as radiofrequency ablation, cryotherapy, and band ligations are promising. This paper is an overview of GAVE and its various endoscopic and medical therapies.

Identifiers

PMID26135263
PMCPMC4423327
OpenAlexW1991272899

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.